Have a personal or library account? Click to login

Antitumor effect of a pyrazolone-based-complex [Cu(PMPP-SAL)(EtOH)] against murine melanoma B16 cell in vitro and in vivo

Open Access
|May 2020

References

  1. 1. C. Cerchia and A. Lavecchia, Small molecule drugs and targeted therapy for melanoma: Current strategies and future directions, Curr. Med. Chem. 24 (2017) 1–33; https://doi.org/10.2174/092986732466617041416393710.2174/092986732466617041416393728413965
  2. 2. T. Zhang, Y. R. Suryawanshi, H. M. Woyczesczyk and K. Essani, Targeting melanoma with cancerkilling viruses, Open. Virol. J. 11 (2017) 28–47; https://doi.org/10.2174/187435790171101002810.2174/1874357901711010028542017228567163
  3. 3. P. Diamantopoulos and H. Gogas, Melanoma immunotherapy dominates the field, Ann. Transl. Med.4 (2016) 269; https://doi.org/10.21037/atm.2016.06.3210.21037/atm.2016.06.32497137927563656
  4. 4. A. A. Tarhini and S. S. Agarwala, Cutaneous melanoma: available therapy for metastatic disease, Dermatol. Ther. 19 (2010) 19–25; https://doi.org/10.1111/j.1529-8019.2005.00052.x10.1111/j.1529-8019.2005.00052.x16405566
  5. 5. P. C. Bruijnincx and P. J. Sadler, New trends for metal complexes with anticancer activity, Curr. Opin. Chem. Biol.12 (2008) 197–206; https://doi.org/10.1016/j.cbpa.2007.11.01310.1016/j.cbpa.2007.11.013292302918155674
  6. 6. Y. Jung and S. J. Lippard, Direct cellular responses to platinum-induced DNA damage, Chem. Rev. 107 (2010) 1387–407; https://doi.org/10.1002/chin.20073127010.1002/chin.200731270
  7. 7. M. S. Soengas and S. W. Lowe, Apoptosis and melanoma chemoresistance, Oncogene22 (2003) 3138–3151; https://doi.org/10.1038/sj.onc.120645410.1038/sj.onc.120645412789290
  8. 8. I. E. León, V. Porro, S. Astrada, M. G. Egusquiza, C. I. Cabello, M. Bollati-Fogolin and S. B. Etcheverry, Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model, Chem. Biol. Interact. 222 (2014) 87–96; https://doi.org/10.1016/j.cbi.2014.10.01210.1016/j.cbi.2014.10.01225451568
  9. 9. J. Zhao, S. Gou and F. Liu, Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand, Chemistry20 (2014) 15216–15225; https://doi.org/10.1002/chem.20140409010.1002/chem.20140409025256173
  10. 10. S. Iglesias, N. Alvarez, M. H. Torre, E. Kremer, J. Ellena, R. R. Ribeiro, R. P. Barroso, A. J. Costafilho, M. G. Kramer and G. Facchin, Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper complexes for the treatment of cancer, J. Inorg. Biochem. 139 (2014) 117–123; https://doi.org/10.1016/j.jinorgbio.2014.06.00710.1016/j.jinorgbio.2014.06.00725033418
  11. 11. J. Lv, T. T. Liu, S. L. Cai, X. Wang, L. Liu and Y. M. Wang, Synthesis, structure and biological activity of cobalt (ii) and copper (ii) complexes of valine-derived Schiff bases, J. Inorg. Biochem.100 (2006) 1888–1896; https://doi.org/10.1016/j.jinorgbio.2006.07.01410.1016/j.jinorgbio.2006.07.01416965817
  12. 12. V. M. Leovac, G. A. Bogdanović, L. S. Jovanović, L. Joksović, V. Marković, M. D. Joksović, S. M. Denčić, A. Isaković, I. Marković and F. W. Heinemann, Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl--3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde, J. Inorg. Biochem.105 (2011) 1413–1421; https://doi.org/10.1016/j.jinorgbio.2011.07.02110.1016/j.jinorgbio.2011.07.02121955843
  13. 13. X. Q. Zhou, Y. Li, D. Y. Zhang, Y. Nie, Z. J. Li, W. Gu, X. Liu, J. L. Tian and S. P. Yan, Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis, Eur. J. Med. Chem. 114 (2016) 244–256; https://doi.org/10.1016/j.ejmech.2016.02.05510.1016/j.ejmech.2016.02.05526994692
  14. 14. X. H. Wang, D. Z. Jia, Y. J. Liang, S. L. Yan, Y. Ding, L. M. Chen, Z. Shi, M. S. Zeng, G. F. Liu and L. W. Fu, Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway, Cancer. Lett. 249 (2007) 256–270; https://doi.org/10.1016/j.canlet.2006.09.00810.1016/j.canlet.2006.09.00817055640
  15. 15. C. Kou, J. Zhao, Y. Li, G. Xu and S. Sun, Acute toxicity test of different doses of copper complex of pyrazolone derivatives in mice, Chin. Hosp. Pharm. J. 36 (2016) 821–825 (In Chinese).
  16. 16. G. C. Xu, L. Zhang, L. Liu, G. F. Liu and D. Z. Jia, Syntheses, characterization and crystal structures of mixed-ligand Cu(II), Ni(II) and Mn(II) complexes of (1-phenyl-3-methyl-4-propenylidene-5--pyrazolone)-salicylidene hydrazide containing ethanol or pyridine as a co-ligand, Polyhedron27 (2008) 12–24; https://doi.org/10.1016/j.poly.2007.08.04510.1016/j.poly.2007.08.045
  17. 17. J. Zhao, L. Zhang, J. Li, T. Wu, M. Wang, G. Xu, F. Zhang, L. Liu, J. Yang and S. Sun, A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway, Chem. Biol. Interact. 231 (2015) 1–9; https://doi.org/10.1016/j.cbi.2015.02.00410.1016/j.cbi.2015.02.00425684395
  18. 18. Q. L. Wu, X. P. Wu, Y. J. Liang, L. M. Chen, Y. Ding and L. W. Fu, P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells, World. J. Gastroenterol.11 (2005) 3544; https://doi.org/10.3748/wjg.v11.i23.354410.3748/wjg.v11.i23.3544431595715962371
  19. 19. C. Chang, T. Wu, M. Wang, G. Xu and S. Sun, Antitumor effect of cadmium(II) complex of pyrazolone derivatives on melanoma B16 cells in vitro and in vivo, Chin. J. Pharmacol. Toxicol. 31 (2017) 405–413 (In Chinese).
  20. 20. G. Resta, G. Anania, F. Messina, D. D. Tullio, G. Ferrocci, F. Zanzi, D. Pellegrini, R. Stano, G. Cavallesco, G. Azzena and S. Occhionorelli, Jejuno-jejunal invagination due to intestinal melanoma, World. J. Gastroenterol. 13 (2007) 310; https://doi.org/10.3748/wjg.v13.i2.31010.3748/wjg.v13.i2.310406596417226915
  21. 21. A. Dayton, K. Selvendiran, S. Meduru, M. Khan, M. L. Kuppusamy, S. Naidu, T. Ka´lai, K. Hideg and P. Kuppusamy, Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function complex, J. Pharmacol. Exp. Ther. 339 (2011) 350–357; https://doi.org/10.1124/jpet.111.18368110.1124/jpet.111.183681319999421799049
  22. 22. H. Yang, D. Chen, Q. C. Cui, X. Yuan and Q. P. Dou, Celastrol, a triterpene extracted from the chinese “thunder of god vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice, Cancer. Res. 66 (2006) 4758; https://doi.org/10.1158/0008-5472.can-05-452910.1158/0008-5472.CAN-05-452916651429
  23. 23. W. Jiang, J. Cao, B. Pan and Y. Yu, Clinical significance of serum vascular endothelial growth factor and b-fibroblast growth factor before and after chemotherapy in patients with small cell lung cancer, Chin. J. Clin. Oncol. 40 (2013) 638–642; https://doi.org/10.3969/j.issn.1000-8179.2013.11.006
  24. 24. S. Imura, H. Miyake, K. Izumi, S. Tashiro and H. Uehara, Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma, J. Med. Invest. 51 (2004) 202; https://doi.org/10.2152/jmi.51.20210.2152/jmi.51.20215460907
  25. 25. H. Yao, P. Cui, D. Xu, Y. Liu, Q. Tian and F. Zhang, A water-soluble polysaccharide from the roots of Polygala tenuifolia suppresses ovarian tumor growth and angiogenesis in vivo, Int. J. Biol. Macromol.107 (2018) 713–718; https://doi.org/10.1016/j.ijbiomac.2017.09.04310.1016/j.ijbiomac.2017.09.04328923567
DOI: https://doi.org/10.2478/acph-2020-0040 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 561 - 575
Accepted on: Feb 10, 2020
Published on: May 13, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:

© 2020 Ayipairi Abula, Jing Zhao, Guancheng Xu, Yijie Li, Surong Sun, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.